Navigation Links
Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
Date:10/6/2008

ipants' safety and privacy. NHLBI -- which supports pediatric research on asthma, heart disease, sickle cell anemia, obesity, and other conditions -- developed the Web site in collaboration with New England Research Institutes and Hands On Productions. Additional support was provided by the NIH Foundation; NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Center for Research Resources; and the National Marfan Foundation.

"Children are not little adults -- their bodies and their brains are still developing," notes Renee R. Jenkins, M.D., president of the American Academy of Pediatrics and professor, Department of Pediatrics and Child Health, Howard University College of Medicine, who appears in the video. "A good example of their unique research needs is understanding how medications affect the developing child and adolescent, and clinical trials are the best way to do that."

Research studies can enroll healthy children or children with specific conditions. They can involve simple observations or health tests, such as weight and height, or more complex tests, vaccines, or treatments for a condition.

In one of the Web site videos, a young teen enrolled in a study of treatments for Fabry disease says that being in a research study is "going to be worth it in the long run, because I'm helping myself and future generations and people who have the disease now." Fabry disease is an inherited condition that can cause severe pain, vision problems, kidney and heart disease, and stroke.

"Children and Clinical Studies" includes a list of questions for parents to consider asking the research team when deciding whether to enroll their child in a study. Other topics include:

-- How institutional review boards monitor studies for safety

-- Who's who on the research team

-- Important terms to know, such as informed consent and assent

-- How a child's participation in a r
'/>"/>

SOURCE NHLBI
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
2. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
3. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
4. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
5. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
6. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
7. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
8. Premier Micronutrient Launches Supplement for Hearing Health
9. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ence Call Scheduled for Tuesday, December 9 at 11:...- , , SOUTH SAN FRANCISCO, Calif., Dec. 1 ...s, Inc. (Nasdaq: SNSS ), a biopharmaceutical com...ion of new oncology therapeutics, today announced ...eloid leukemia (AML) will be presented during the ...
(Date:11/30/2008)... CHICAGO, Dec. 1 Olde...ebral blood flow and a greater number of small blo...sented today at the annual meeting of the Radiolog...The study, conducted at the University of North C...mpare brain scans of older adults who exercise to ...
(Date:11/28/2008)...LIS, Nov. 28 Eli Lilly a...emental New Drug Application (sNDA) from,the U.S....) (duloxetine HCl),for the management of chronic ...the first half of 2009, adding data from a recentl...tis pain of the knee. , The decision does n...
(Date:11/26/2008)... information density, automation and intelligent c...ltrasound to an all new level , , CHICAGO, ... Healthcare ( www.siemens.com/healthcare ) highl... Scanner (ABVS)(1), the world,s first multi-use, ...94th Scientific Assembly and Annual Meeting of the...
Breaking Medicine Technology:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Sexually transmitted disease urinary tract infections may be bad combination for birth defect 22432 1Sexually transmitted disease urinary tract infections may be bad combination for birth defect 22432 2Sexually transmitted disease urinary tract infections may be bad combination for birth defect 22432 3Sickle Cell Drug Underused by Physicians 22429 1Sickle Cell Drug Underused by Physicians 22429 2Global Healer and YouTube Guru Dattatreya Siva Baba Starts Worldwide City Tour on July 2 in New York City 3A Grace Light Is Coming to Solve Mankind 22425 1Global Healer and YouTube Guru Dattatreya Siva Baba Starts Worldwide City Tour on July 2 in New York City 3A Grace Light Is Coming to Solve Mankind 22425 2Warning for teens 3A Teeth and jewelry dont mix 22422 1Warning for teens 3A Teeth and jewelry dont mix 22422 2
...7 - In a late-breaker,presentation at the 42nd Ann...udy of the Liver (EASL), researchers today present...VE 1 clinical trial,which is the first trial to e...ional hepatitis C protease inhibitor telaprevir (T...on (peg-IFN) and,ribavirin (RBV) in treatment-naiv...
... Underway at Nine,Centers, SAN DIEGO, Calif., Apri...armaceutical company, today presented long term,fo...-120, a gene,therapy product in development for th...a 36 percent (p<0.001) reduction in,Parkinson,s sy...red,by the Unified Parkinson,s Disease Rating Scal...
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 2Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 3Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 4
(Date:12/1/2008)...wswire/ -- Medication therapy management,(MTM) pr...rofessionals to its,advisory board. , New ...in Makary, M.D.;,Michael Burcham; and Kevin Hutch... that has helped PharmMD launch and hone its MTM s...rror, misuse, overuse and abuse. MTM is proven,t...
(Date:12/1/2008)...FirstCall/ -- SpectraScience, Inc.,(OTC Bulletin ...pany, today,announced that it has been awarded a ... Tissue Diagnosis. , Jim Hitchin, SpectraScienc...the Company,s optical biopsy technology because it...illance, characterization, diagnosis and treatment...
(Date:12/1/2008)...swire-USNewswire/ -- The United States, fifth hand...hand on Saturday, November 29, as Dr. Warren C. Br...he bandages. , , "Wow, it looks like a perf... at Jewish Hospital. "It,s awesome," said his wif...sky, a New York resident, went on to say, "thanks ...
(Date:12/1/2008)...ndings may help improve treatment for psychiatric ...News) -- Children with lower IQ have an increased ...ralized anxiety disorder and other psychiatric pro...n three decades shows. , Lower childhood IQ was...nd anxiety, as well as an increased risk of having...
Breaking Medicine News(10 mins):Health News:PharmMD Expands Advisory Board 2Health News:SpectraScience Awarded European Patent for Its Optical Biopsy System for Tissue Diagnosis 2Health News:Fifth U.S. Hand Transplant Patient Gets Look at New Hand 2Health News:Low Childhood IQ Tied to Risk of Later Mental Disorders 2
... is reconsidering and mulling over the veracity of.../ a link between heavy cell phone use and an incre...n an academic exercise conducted by researchers at...rking Life who conducted a comparative study betwe...
...Australia to stop the misuse and stocking up of th... automatically// via text messages alerting them t...se drugs at pharmacies. In this new online program...taining pseudoephedrine, they will have to show ph...
...to determine the chemical composition of materials...iruses// especially in complex environmental sampl...hool of Public Health successfully separated, pur...urrogate from a clinical sample within a few hours...
...presence of the dangerous H5N1 strain of bird flu ... Following this news, there has been ample furore... Britain, but officials have been trying their bes...bout the possible spread of the disease in humans....
Other Medicine News:
...hrotek® Precision Hand Instruments were develo...eel, while still having an instrument with the str...ar of the bending or breaking. Arthrotek Hand Inst... to conform to the surgeon's hand. This new genera...
...hrotek® Precision Hand Instruments were develo...eel, while still having an instrument with the str...ar of the bending or breaking. Arthrotek Hand Inst... to conform to the surgeon's hand. This new genera...
...hrotek® Precision Hand Instruments were develo...eel, while still having an instrument with the str...ar of the bending or breaking. Arthrotek Hand Inst... to conform to the surgeon's hand. This new genera...
...hrotek® Precision Hand Instruments were develo...eel, while still having an instrument with the str...ar of the bending or breaking. Arthrotek Hand Inst... to conform to the surgeon's hand. This new genera...
Medicine Products: